Loading
Sections

Skip to content. | Skip to navigation

Contact Information

Tel   (919) 843-6475
Fax  (919) 843-4682

120 Mason Farm Road
5000 D, Genetic Medicine Building
CB#7264
UNC-Chapel Hill
Chapel Hill, NC 27599-7264

Directions & Parking

 
You are here: Home

Welcome to the Department of Genetics

Congratulations!

  • Jim Evans is Principal Investigator of a new four-year grant to fund a project named the North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing (NCGENES). Other faculty members in the Department of Genetics who are Investigators on this grant are Jonathan Berg, Kirk Wilhelmsen, and Karen Weck.  Jim and Jonathan have also published a recent commentary in JAMA in which they discuss the potential benefits and challenges of the use of whole-genome or whole-exome sequencing in a clinical setting.
  • Will Valdar has received a Junior Faculty Development Award from UNC in support of his research for the coming year. These awards are given by the Office of the Executive Vice Chancellor and Provost to support young faculty members in furthering their research.
  • Praveen Sethupathy has been chosen as one of this year's Rising Young Investigators by Genome Technology (registration required). He was cited for his work on MicroRNA, Regulation, and Complex Diseases.
  • Fernando Pardo-Manuel de Villena has been elected Fellow of the American Association for the Advancement of Science.
  • Chuck Perou was presented with a Scientific and Medical Award of Distinction by Susan G. Komen for the Cure® on October 28th

News

  • Ethan Lange is one of the lead authors of an article in the New England Journal of Medicine reporting on the identification of mutations in the HOXB13 gene in a subset of patients with prostate cancer. This is the first gene to be recognized as one in which mutations result in a highly elevated risk (~20 times higher than the general population) of this common type of cancer.
  • Ian Davis is senior author of a study published online ahead of print in Genome Research showing that the EWS-FLI1 fusion protein present in Ewing Sarcoma has chromatin-altering activity, which leads ultimately to transcriptional dysregulation. The discovery could lead to a targeted therapy for this malignant bone and soft tissue tumor of children and young adults.
  • Terry Magnuson is featured in a profile on the UNC-Chapel Hill home page and on the front page of the November 2 issue of the University Gazette, with an emphasis on his role in the NC TraCS Institute.

Events

The Psychiatric Genome-Wide Association Study Consortium, of which Pat Sullivan is a lead investigator, has recently published the results of two large studies in Nature Genetics. These studies report on associations between newly recognized loci with schizophrenia and bipolar disorder, as well as confirmation in a very large patient population of loci that had previously been implicated in schizophrenia.